Sort
30,917 grants matching “tumor microenvironment”
Development of irreversible electroporation-based rational combinations to potentiate the activity of cancer immunotherapy against pancreatic ductal adenocarcinoma
$552,266Chun Li · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Reactive Stroma and Tumor Associated Macrophages in Prostate Cancer Progression
$552,256Kenneth J. Pienta · University Of Michigan At Ann Arbor · U01 · FY2011 · CA
Optimizing Novel Immunotherapy Combinations Targeting the Tumor Microenvironment in Canine Spontaneous Osteosarcoma
$552,171Steven W. Dow · Colorado State University · U01 · FY2022 · CA
A deubiquitination module controls Treg adaptation to tumor microenvironment
$552,115Deyu Fang · Northwestern University At Chicago · R01 · FY2023 · CA
Re-wiring PDAC Tumor Immunity Through Dendritic Cells
$551,987David G Denardo · Washington University · R01 · FY2021 · CA
Recognizing the tumor ecosystem: Integrating stromal and cancer antigen signals to achieve precision recognition of solid tumors by CAR T cells
$551,974Wendell A Lim · University Of California, San Francisco · R01 · FY2023 · CA
Neoadjuvant Immunotherapy with Intratumoral CPG and PD-1 Blockade in Melanoma
$551,927Hassane M Zarour · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Modulation of the tumor microenvironment with probiotic therapies
$551,862Tal Danino · Columbia Univ New York Morningside · R01 · FY2023 · CA
Dynamic Interactions of the Ovarian-Fallopian Axis in High Grade Serous Ovarian Cancer
$551,809Joanna E Burdette · University Of Illinois At Chicago · R01 · FY2019 · CA
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture
$551,690Simone Krebs · Sloan-Kettering Inst Can Research · R37 · FY2022 · CA
CANCAN-RUTGERS
$551,676Eileen White · Rutgers Biomedical And Health Sciences · OT2 · FY2023 · CA
EPHA2 Receptor Signaling in Breast Cancer Mechanotransduction
$551,618Elena B Pasquale · Sanford Burnham Prebys Medical Discovery Institute · R01 · FY2022 · CA
Developing isoform-selective Hsp90 inhibitors for monotherapy and enhanced immunotherapy against lethal prostate cancer
$551,601Brian S J Blagg · University Of Notre Dame · R01 · FY2025 · CA
Differential TGF-Beta Signaling in Bone Microenviroment: Impact on Tumor Growth
$551,442Theresa A Guise · Indiana University Indianapolis · U01 · FY2011 · CA
Targeting Lipid Unsaturation in Ovarian Cancer Stem Cells
$551,416Daniela E Matei · Northwestern University At Chicago · R01 · FY2019 · CA
Hyperplexed Quantum Dots for Multidimensional Cell Classification in Intact Tissue
$551,348Andrew Michael Smith · University Of Illinois At Urbana-Champaign · R01 · FY2023 · EB
Modeling the role and regulation of reactive stroma in breast ductal carcinoma microinvasions
$551,254Katarzyna Anna Rejniak · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2024 · CA
Overcoming obesity-associated immunotherapy resistance in renal cancer
$551,148Lyse A Norian · University Of Alabama At Birmingham · R01 · FY2023 · CA
Tumor Endothelial Cell Regulation of Pro-Metastatic Fibrin Matrices
$551,095Chad V Pecot · Univ Of North Carolina Chapel Hill · R01 · FY2024 · CA
Innate lymphoid cell regulation of the host-microbiota interactions in cancer
$551,090Gregory F Sonnenberg · Weill Medical Coll Of Cornell Univ · R01 · FY2024 · CA
CANCAN-RUTGERS
$551,024Eileen White · Rutgers Biomedical And Health Sciences · OT2 · FY2025 · CA
Systems analysis of cell-cell communication networks and immune activity in the melanoma tumor microenvironment
$551,007Kathryn Miller-Jensen · Yale University · U01 · FY2022 · CA
Predicting Prostate Cancer Aggressiveness
$550,965Alexander Robertson Allan Anderson · H. Lee Moffitt Cancer Ctr & Res Inst · U01 · FY2015 · CA
Olympus FV1000MPE Multiphoton Microscope
$550,894Teng-Leong Chew · Northwestern University At Chicago · S10 · FY2012 · OD
Development of microRNA (miR)-based cell-targeted polymeric nanoparticles for myeloma therapy
$550,877Ruben D Carrasco · Dana-Farber Cancer Inst · R01 · FY2025 · CA